In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Using Hexapeptide Substrates

In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Using Hexapeptide Substrates

The SARS-CoV-2 main protease (M<sup>pro</sup>) is essential for the life cycle of the COVID-19 virus. It cleaves the two polyproteins at 11 positions to generate mature proteins for virion formation. The cleavage site on these polyproteins is known to be Leu-Gln↓(Ser/Ala/Gly). A range of...

Full description

Bibliographic Details
Main Authors:	Sophakama Zabo, Kevin Alan Lobb
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Viruses
Subjects:	SARS-CoV-2 main protease protein substrate multi-conformer substrate library molecular docking molecular dynamics PCA
Online Access:	https://www.mdpi.com/1999-4915/15/7/1480

Similar Items

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M<sup>pro</sup>)
by: Mohamed S. Alesawy, et al.
Published: (2021-05-01)

No Substrate Left behind—Mining of Shotgun Proteomics Datasets Rescues Evidence of Proteolysis by SARS-CoV-2 3CL<sup>pro</sup> Main Protease
by: Peter A. Bell, et al.
Published: (2023-05-01)

HIV-1 Gag Non-Cleavage Site PI Resistance Mutations Stabilize Protease/Gag Substrate Complexes In Silico via a Substrate-Clamp
by: Gary S. Laco
Published: (2021-11-01)

Insights into the Dynamics and Binding of Two Polyprotein Substrate Cleavage Points in the Context of the SARS-CoV-2 Main and Papain-like Proteases
by: Zainab Kemi Sanusi, et al.
Published: (2022-11-01)

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Inhibitors
by: Mahmoud A. A. Ibrahim, et al.
Published: (2021-04-01)

In Silico Analysis of Peptide-Based Derivatives Containing Bifunctional Warheads Engaging Prime and Non-Prime Subsites to Covalent Binding SARS-CoV-2 Main Protease (M<sup>pro</sup>)
by: Simone Brogi, et al.
Published: (2022-05-01)

Characterization of host substrates of SARS-CoV-2 main protease
by: Ivonne Melano, et al.
Published: (2023-08-01)

Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M<sup>pro</sup>
by: Davide Bassani, et al.
Published: (2022-01-01)

Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 M<sup>pro</sup>
by: Mohd Saeed, et al.
Published: (2021-03-01)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitors
by: Maria Nuria Peralta-Moreno, et al.
Published: (2023-04-01)

Molecular Insights into Substrate Binding of the Outer Membrane Enzyme OmpT
by: Yubo Zhang, et al.
Published: (2023-01-01)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-06-01)

In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
by: Seyyed Sasan Mousavi, et al.
Published: (2021-09-01)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024-01-01)

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
by: Aniruddhya Mukherjee, et al.
Published: (2023-07-01)

N-Terminomics Strategies for Protease Substrates Profiling
by: Mubashir Mintoo, et al.
Published: (2021-08-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
by: Ishola Abeeb Akinwumi, et al.
Published: (2023-12-01)

Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein
by: Kalliopi Moschovou, et al.
Published: (2023-11-01)

Profiling Substrate Specificity of the SUMO Protease Ulp1 by the YESS–PSSC System to Advance the Conserved Mechanism for Substrate Cleavage
by: Faying Zhang, et al.
Published: (2022-10-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

An intermolecular salt bridge linking substrate binding and P1 substrate specificity switch of arterivirus 3C-like proteases
by: Qian Chen, et al.
Published: (2022-01-01)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
by: Menghan Gao, et al.
Published: (2023-07-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
by: Annamaria Martorana, et al.
Published: (2020-07-01)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023-04-01)

Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies
by: Raju Das, et al.
Published: (2023-02-01)

Computational Screening of Phenylamino-Phenoxy-Quinoline Derivatives against the Main Protease of SARS-CoV-2 Using Molecular Docking and the ONIOM Method
by: Suwicha Patnin, et al.
Published: (2022-03-01)

Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates
by: Shitao Zhang, et al.
Published: (2021-10-01)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
by: Thrigulla Saketh Ram, et al.
Published: (2022-01-01)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors
by: Laurent Soulère, et al.
Published: (2023-06-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
by: Fangya Li, et al.
Published: (2023-06-01)

Identification of 7-hydroxyindole as an alternative substrate of MauG by in silico and in vitro analysis
by: Heejin Nam, et al.
Published: (2023-05-01)

POTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKINGPOTENSI DAUN TEH HIJAU (Camellia sinensis) SEBAGAI INHIBITOR MAIN PROTEASE (Mpro) COVID-19: SEBUAH STUDI MOLECULAR DOCKING
by: Haidar Ali Hamzah, et al.
Published: (2022-10-01)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
by: Alejandro Llanes, et al.
Published: (2020-12-01)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022-10-01)

Substrate Specificity of Chimeric Enzymes Formed by Interchange of the Catalytic and Specificity Domains of the 5<sup>′</sup>-Nucleotidase UshA and the 3<sup>′</sup>-Nucleotidase CpdB
by: Alicia Cabezas, et al.
Published: (2021-04-01)

Modified Enzyme Substrates for the Detection of Bacteria: A Review
by: Laura Pala, et al.
Published: (2020-08-01)

Predicting Structural Susceptibility of Proteins to Proteolytic Processing
by: Evgenii V. Matveev, et al.
Published: (2023-06-01)

Leveraging SARS-CoV-2 Main Protease (M<sup>pro</sup>) for COVID-19 Mitigation with Selenium-Based Inhibitors
by: Viviana De Luca, et al.
Published: (2024-01-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran
by: Nathaphat Harnkit, et al.
Published: (2022-09-01)